Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BeiGene
Biotech
Pfizer’s reputation wrangler plans departure—Chutes & Ladders
Pfizer’s longtime reputation wrangler plans departure. AI unicorn lassos new president. Jazz switches tempo with female CEO.
Darren Incorvaia
,
Zoey Becker
Jul 11, 2025 8:30am
Novartis inks $175M option deal for Sironax’s BBB tech
Jul 9, 2025 10:29am
BeiGene drops TIGIT drug over poor phase 3 lung cancer prospects
Apr 3, 2025 8:05am
BeiGene, Brii and Ideaya ring in 2025 with deals
Jan 2, 2025 8:30am
BeiGene inks $150M deal to follow cancer trail blazed by Amgen
Dec 13, 2024 9:11am
AbbVie sues BeiGene over blood cancer drug trade secrets
Sep 11, 2024 10:17am